pGTM_Sumo2-N-8XHis-Plpro-C111S
(Plasmid
#234472)
-
PurposeExpresses SARS-CoV-2 Nsp3 residues 746-1063 C111S with an activity abolishing mutation for the purification of this PLpro protease. Following Sumo Protease Cleavage an N-term 8xHis Tag is retained
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 234472 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepET15Sumo2_NESG
-
Backbone manufacturerNovagen/Northeast Structural Genomics Consortium
- Backbone size w/o insert (bp) 5680
- Total vector size (bp) 6664
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namePLpro
-
Alt nameNsp3
-
SpeciesSARS-CoV-2
-
Insert Size (bp)984
-
GenBank IDWQM42602.1 PRO_0000449637
-
Entrez GeneORF1ab (a.k.a. GU280_gp01)
- Promoter T7 lac
-
Tags
/ Fusion Proteins
- 6xHis-Sumo (N terminal on backbone)
- 8xHis (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer T7 Forward
- 3′ sequencing primer T7 Reverse
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGTM_Sumo2-N-8XHis-Plpro-C111S was a gift from Gaetano Montelione (Addgene plasmid # 234472 ; http://n2t.net/addgene:234472 ; RRID:Addgene_234472) -
For your References section:
Protocol for production and characterization of SARS-CoV-2 PL(pro) in Escherichia coli. De Falco A, Greene-Cramer R, Shurina BA, Zakian S, Acton TB, Ramelot TA, Montelione GT. STAR Protoc. 2025 Sep 19;6(3):103952. doi: 10.1016/j.xpro.2025.103952. Epub 2025 Jul 18. 10.1016/j.xpro.2025.103952 PubMed 40682779